CANCER RESEARCH Journal
Overview
publication venue for
- Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction. 77:4328-4341. 2017
- Human T-Cell Leukemia Virus I Tax Protein Sensitizes p53-Mutant Cells to DNA Damage. 68:4843-4852. 2008
- Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue.. 67:11798-810. 2007
- Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.. 62:3609-14. 2002
- MYB exhibits racially disparate overexpression and clinicopathologic association in prostate cancer: significance as a predictor of biochemical recurrence 2022
- Detect early tumor relapse in high-risk breast cancer 2019
- PSMA glycosylation and aggressive prostate cancer progression 2019
- The critical role of seven-in-absentia (SINA) family E3 ligases in normal development and oncogenic K-RAS-driven human cancer 2019
- Underreporting of race in genomic sequencing studies increases cancer health information disparities 2019
- Conquering undruggable oncogenic K-RAS-driven incurable metastatic cancer, and delivering precision medicine at neoadjuvant settings 2018
- Conquering undruggable oncogenic K-RAS-driven incurable metastatic cancer, and delivering precision medicine at neoadjuvant settings 2018
- From profiling to function: A role for microRNA miR-888 in promoting prostate cancer progression 2015
- Inhibition of late-stage tumor growth of human pancreatic and triple-negative breast cancer by blocking the most downstream "gatekeeper" signaling module, SIAH E3 ligase, in the oncogenic ERBB/K-RAS signaling pathway 2015
- Novel altered mitochondrial genes in prostate cancer progression 2015
- Proteomic analysis of SIAH2 E3 ligase complex in oncogenic K-Ras-driven cell transformation in human cancer 2015
- Developing a new and potent anti-K-RAS strategy by inhibiting SIAH E3 ligase, the most downstream "gatekeeper" in the oncogenic K-RAS signal pathway, to block well-established pancreatic tumor growth 2015
- Differential plectin isoform expression correlates with aggressive prostate cancer phenotypes 2014
- Inhibiting SIAH2 E3 ligase function disrupts focal adhesion and cell junction, inhibits cell mobility and attachment, and blocks tumor invasion and metastasis in oncogenic K-Ras-driven tumors 2014
- Inhibition of SIAH E3 ligase function leads to increased cell death in metastatic human cancer cells 2014
- Proteomic analysis of SIAH2 E3 ligase complex in oncogenic K-Ras-driven cell transformation and oncogenesis 2014
- Attacking the most downstream "gatekeeper" signaling module in the oncogenic ERBB/K-RAS signaling pathway to block tumorigenesis and metastasis in human cancer 2013
- Oncogenic K-RAS activation promotes cell motility, invasion, tumor growth and cancer metastasis via its most downstream signaling module, the SIAH2-ependent proteolytic machinery, in the highly aggressive and metastatic human cancer cells 2011
- Proteomic analysis reveals a network of inflammatory genes in epidermis associated with skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice 2011
- Targeting SIAH2-dependent proteolysis downstream of the HER2/EGFR/RAS signaling pathway to inhibit tumorigenesis and metastasis of highly invasive human breast cancer 2011
- The SIAH2-SMAD2/3/4 antagonism downstream of the K-RAS and TGF beta signaling pathways during tumor initiation, progression and metastasis of human cancer 2011
- Inhibit SIAH E3 Ligase, a Downstream Signaling Module Required for the HER2/EGFR/RAS Signal Transduction, To Block Tumorigenesis and Metastasis of Highly Invasive Human Breast Cancers 2010
- Expressed prostatic secretions in urine and directly collected prostatic fluids as enriched sources of prostate cancer protein biomarkers 2009
- Differential lectin capture profiling and identification of serum glycoproteins to detect and monitor prostate cancer 2006
- Proteomic profiles predict therapy response in patients with squamous cell carcinoma of the head and neck 2006
Identity
International Standard Serial Number (ISSN)
- 0008-5472
Electronic International Standard Serial Number (EISSN)
- 1538-7445